Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD

Journal of Nuclear Medicine

Volumn 46, Issue 1, 2005, Pages 184-189

  Pichler, Bernd J ^a,b   Kneilling, Manfred ^b   Haubner, Roland ^a   Braumüller, Heidi ^b   Schwaiger, Markus ^a   Röcken, Martin ^b   Weber, Wolfgang A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Animal imaging; Autoradiography; Inflammation; Molecular maging; PET; Radiopharmaceuticals

Indexed keywords

CYCLOPEPTIDE; GALACTOARGINYLGLYCYLASPARTIC ACID F 18; GLUCOARGINYLGLYCYLASPARTIC ACID I 125; HAPTEN; LIGAND; PICRYL CHLORIDE; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUOROGALACTO RGD; FLUOROGALACTO-RGD; GALACTOSE; GLUCOSIDE; IODOGLUCO RGD; IODOGLUCO-RGD; OLIGOPEPTIDE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTORADIOGRAPHY; CHRONIC DISEASE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIAGNOSTIC IMAGING; DRUG SPECIFICITY; DRUG UPTAKE; EAR; HISTOPATHOLOGY; INFLAMMATORY DISEASE; ISOTOPE LABELING; LYMPHOCYTIC INFILTRATION; MORPHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NON INVASIVE PROCEDURE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; SKIN SENSITIZATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONTACT DERMATITIS; EVALUATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING;

ANIMALS; AUTORADIOGRAPHY; DERMATITIS, CONTACT; GALACTOSE; GLUCOSIDES; HYPERSENSITIVITY, DELAYED; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PICRYL CHLORIDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 15044364765     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001;305:285-298.
2. Eliceiri BP, Cheresh DA. The role of alpha(v) integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999;103:1227-1230.
3. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem. 2000;275:21785-21788.
4. Xiong JP, Stehle T, Zhang R, et al. Crystal structure of the extracellular segment of integrin alpha(v)beta(3) in complex with an Arg-Gly-Asp ligand. Science. 2002;296:151-155.
5. Haubner R, Finsinger D, Kessler H. Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors for alpha(v)beta(3) integrins for a new cancer therapy. Angew Chem Int Ed Engl. 1997;36:1374-1389.
6. Haubner RH, Wester HJ, Weber WA, Schwaiger M. Radiotracer-based strategies to image angiogenesis. Q J Nucl Med. 2003;47:189-199.
7. Christofidou-Solomidou M, Bridges M, Murphy GF, Albelda SM, DeLisser HM. Expression and function of endothelial cell alpha(v) integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. Am J Pathol. 1997;151:975-983.
8. Bishop GG, McPherson JA, Sanders JM, et al. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation. 2001;103:1906-1911.
9. Pablos JL, Santiago B, Galindo M, et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol. 2003;170:2147-2152.
10. Creamer D, Allen M, Sousa A, Poston R, Barker J. Altered vascular endothelium integrin expression in psoriasis. Am J Pathol. 1995;147:1661-1667.
11. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an alphav-beta3 antagonist. J Clin Invest. 1999;103:47-54.
12. Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002;61(suppl 2):ii96-ii99.
13. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile, J Immunol. 1997;159:2484-2491.
14. Ross R, Reske-Kunz AB. The role of NO in contact hypersensitivity. Int Immunopharmacol. 2001;1:1469-1478.
15. Haubner R, Wester H-J, Burkhart F, et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001;42:326-336.
16. l8F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 2001;61:1781-1785.
17. Beer AJ, Haubner R, Essler M, et al. Non-invasive imaging of αvβ3-expression with F-18-galacto-RGD and PET: initial results in patients [abstract]. J Nucl Med. 2004;45(suppl):192P.
18. l8F]galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjugate Chem. 2004;15:61-69.
19. Ziegler SI, Pichler BJ, Boening G, et al. A prototype high-resolution animal positron tomograph with avalanche photodiode arrays and LSO crystals. Eur J Nucl Med. 2001;28:136-143.
20. Biedermann T, Kneilling M, Mailhammer R, et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med. 2000;192:1441-1452.
21. Krasteva M, Kehren J, Ducluzeau MT, et al. Contact dermatitis I: pathophysiology of contact sensitivity. Eur J Dermatol. 1999;9:65-77.
22. Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol. 1995;105:749-755.
23. Zhang N, Fang Z, Contag PR, Purchio AF, West DB. Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood. 2004;103:617-626.
24. Dieli F, Sireci G, Scire E, Salerno A, Bellavia A. Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice. Immunology. 1999;98:71-79.
25. Lange-Asschenfeldt B, Weninger W, Velasco P, et al. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood. 2002;99:538-545.
26. Maxfield SR, Moulder K, Koning F, et al. Murine T cells express a cell surface receptor for multiple extracellular matrix proteins: identification and characterization with monoclonal antibodies. J Exp Med. 1989;169:2173-2190.
27. Sixt M, Hallmann R, Wendler O, Scharffetter-Kochanek K, Sorokin LM. Cell adhesion and migration properties of beta 2-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules: relevance for leukocyte extravasation. J Biol Chem. 2001;276:18878-18887.
28. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis. 2001;1:326-333.